| Antibiotic efflux pumps F Van Bambeke, E Balzi, PM Tulkens Biochemical pharmacology 60 (4), 457-470, 2000 | 616 | 2000 |
| Quinolones in 2005: an update F Van Bambeke, JM Michot, J Van Eldere, PM Tulkens Clinical Microbiology and infection 11 (4), 256-280, 2005 | 530 | 2005 |
| Pharmacodynamic Evaluation of the Intracellular Activities of Antibiotics against Staphylococcus aureus in a Model of THP-1 Macrophages M Barcia-Macay, C Seral, MP Mingeot-Leclercq, PM Tulkens, ... Antimicrobial agents and chemotherapy 50 (3), 841-851, 2006 | 317 | 2006 |
| Glycopeptide antibiotics: from conventional molecules to new derivatives F Van Bambeke, Y Van Laethem, P Courvalin, PM Tulkens Drugs 64, 913-936, 2004 | 287 | 2004 |
| Antibiotic efflux pumps in prokaryotic cells: occurrence, impact on resistance and strategies for the future of antimicrobial therapy F Van Bambeke, Y Glupczynski, P Plesiat, JC Pechere, PM Tulkens Journal of Antimicrobial Chemotherapy 51 (5), 1055-1065, 2003 | 276 | 2003 |
| Inhibitors of bacterial efflux pumps as adjuvants in antibiotic treatments and diagnostic tools for detection of resistance by efflux F Van Bambeke, VJ Lee Recent patents on anti-infective drug discovery 1 (2), 157-175, 2006 | 242 | 2006 |
| Intracellular pharmacodynamics of antibiotics S Carryn, H Chanteux, C Seral, MP Mingeot-Leclercq, F Van Bambeke, ... Infectious Disease Clinics 17 (3), 615-634, 2003 | 236 | 2003 |
| Intracellular Staphylococcus aureus persisters upon antibiotic exposure F Peyrusson, H Varet, TK Nguyen, R Legendre, O Sismeiro, JY Coppée, ... Nature communications 11 (1), 2200, 2020 | 215 | 2020 |
| Contrasting effects of acidic pH on the extracellular and intracellular activities of the anti-gram-positive fluoroquinolones moxifloxacin and delafloxacin against … S Lemaire, PM Tulkens, F Van Bambeke Antimicrobial agents and chemotherapy 55 (2), 649-658, 2011 | 202 | 2011 |
| Antibiotic activity against small-colony variants of Staphylococcus aureus: review of in vitro, animal and clinical data LG Garcia, S Lemaire, BC Kahl, K Becker, RA Proctor, O Denis, ... Journal of antimicrobial chemotherapy 68 (7), 1455-1464, 2013 | 196 | 2013 |
| Cellular pharmacodynamics and pharmacokinetics of antibiotics: current views and perspectives F Van Bambeke, M Barcia-Macay, S Lemaire, PM Tulkens Current Opinion in Drug Discovery and Development 9 (2), 218, 2006 | 193 | 2006 |
| ABC multidrug transporters: target for modulation of drug pharmacokinetics and drug-drug interactions B Marquez, F Van Bambeke Current drug targets 12 (5), 600-620, 2011 | 192 | 2011 |
| Quantitative analysis of gentamicin, azithromycin, telithromycin, ciprofloxacin, moxifloxacin, and oritavancin (LY333328) activities against intracellular Staphylococcus aureus … C Seral, F Van Bambeke, PM Tulkens Antimicrobial agents and chemotherapy 47 (7), 2283-2292, 2003 | 190 | 2003 |
| Gentamicin-induced apoptosis in LLC-PK1 cells: involvement of lysosomes and mitochondria H Servais, P Van Der Smissen, G Thirion, G Van der Essen, ... Toxicology and applied pharmacology 206 (3), 321-333, 2005 | 174 | 2005 |
| The bacterial envelope as a target for novel anti-MRSA antibiotics F Van Bambeke, MP Mingeot-Leclercq, MJ Struelens, PM Tulkens Trends in pharmacological sciences 29 (3), 124-134, 2008 | 173 | 2008 |
| Comparative intracellular (THP-1 macrophage) and extracellular activities of β-lactams, azithromycin, gentamicin, and fluoroquinolones against Listeria monocytogenes at … S Carryn, F Van Bambeke, MP Mingeot-Leclercq, PM Tulkens Antimicrobial agents and chemotherapy 46 (7), 2095-2103, 2002 | 167 | 2002 |
| Glycopeptides in clinical development: pharmacological profile and clinical perspectives F Van Bambeke Current opinion in pharmacology 4 (5), 471-478, 2004 | 165 | 2004 |
| Safety profile of the respiratory fluoroquinolone moxifloxacin: comparison with other fluoroquinolones and other antibacterial classes F Van Bambeke, PM Tulkens Drug safety 32, 359-378, 2009 | 162 | 2009 |
| Multidrug-resistant Streptococcus pneumoniae infections: current and future therapeutic options F Van Bambeke, RR Reinert, PC Appelbaum, PM Tulkens, ... Drugs 67, 2355-2382, 2007 | 151 | 2007 |
| Macrolides: pharmacokinetics and pharmacodynamics F Van Bambeke, PM Tulkens International Journal of Antimicrobial Agents 18, 17-23, 2001 | 150 | 2001 |
Paul M. TulkensProfessor Emeritus / Professor invitedVerified email at facm.ucl.ac.be
